COMMENTARY: Are infections key environmental factors in MS? SEE also PRO and CON POSITION

Etiology and Pathogenesis of MS

October 30, 2010

The copyright for all illustrations and pictures has been heeded by all authors to the best of their knowledge. If you feel your copyright has been infringed in any way or if you have any questions, do contact us by clicking on this link, please.

Further Lectures

THE PLACE OF SURROGATE ENDPOINTS IN THE DEVELOPMENT NEW NEUROLOGICAL MEDICINES

Biomarkers in Diagnositcs of Neurological Disorders

UPDATE ON CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING–REMITTING MULTIPLE SCLEROSIS

New Players in MS

LAQUINIMOD: A NEW ORAL IMMUNOMODULATOR FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS

New Players in MS

TERIFLUNOMIDE

New Players in MS

Go to congress

• Infos